Browsing Category
Company Profiles
28 posts
Defence Holdings (LSE: ALRT) company profile: How the former Guild Esports listing pivoted into UK defence software
Defence Holdings PLC has transformed from the listed company formerly known as Guild Esports into an early-stage defence software and investment platform. Its first £226,000 UK Ministry of Defence contract and partnerships with Oracle and Whitespace provide initial validation, but the short contract duration, operating losses and rapid expansion of its share count leave the wider investment case unproven.
Avacta Group (AIM: AVCT) company profile: Can pre|CISION make potent cancer drugs safer and more targeted?
Avacta Group plc is developing peptide drug conjugates intended to release potent anticancer payloads primarily within the tumour microenvironment. Early AVA6000 findings and the launch of the AVA6103 trial have strengthened the scientific case, but larger clinical studies, partnership funding and management of the remaining convertible bond will determine whether pre|CISION creates sustainable shareholder value.
Rheinmetall AG company profile: How Europe’s rearmament created a €73bn defence backlog
Rheinmetall AG has become one of the central industrial beneficiaries of Europe’s rearmament, building a €73 billion backlog across military vehicles, ammunition, air defence, digital systems and warships. Its operational momentum remains strong, but a sharp 2026 share-price correction shows that investors are questioning how quickly political spending commitments can become profitable deliveries.
MP Materials company profile: How Pentagon and Apple deals transformed America’s rare earth miner
MP Materials Corp. is transforming the Mountain Pass rare earth mine into an integrated American supply chain spanning mineral extraction, refining, metal production, recycling and permanent magnets. Pentagon price protection, long-term demand from Apple Inc. and General Motors Company, and the planned 10X facility have reduced some commercial risks, but profitable downstream execution remains the decisive test.
CoreWeave company profile: How a crypto miner built a $99.4bn AI cloud backlog
CoreWeave has transformed from a cryptocurrency-mining operation into one of the world’s fastest-growing artificial intelligence cloud providers, securing major commitments from Microsoft Corporation, OpenAI, Meta Platforms, Inc., Anthropic and Jane Street. Its $99.4 billion revenue backlog offers extraordinary visibility, but heavy debt, customer concentration and a planned $31 billion to $35 billion capital programme make execution as important as demand.
Nebius Group company profile: How the former Yandex parent became an NVIDIA-backed AI cloud contender
Nebius Group has rapidly transformed the international assets retained after the breakup of Yandex into a full-stack artificial intelligence cloud platform. Contracts with Microsoft Corporation and Meta Platforms, Inc., a $2 billion investment from NVIDIA Corporation and sharply accelerating revenue have strengthened its position, but capital intensity, customer concentration and a premium valuation leave little room for execution errors.
IREN Limited company profile: Can a Bitcoin miner become a $4bn AI cloud platform?
IREN Limited is attempting one of the technology sector’s most ambitious business-model transitions, converting power-rich Bitcoin mining infrastructure into an artificial intelligence cloud platform. Contracts with Microsoft Corporation, NVIDIA Corporation and several AI developers have strengthened its growth case, but the gap between contracted annualised revenue and recognised financial results remains the critical issue for investors.
Orchid Pharma company profile: business model, financials, and growth outlook (2026 Edition)
Orchid Pharma Limited company profile: cephalosporin API leader, FY2025 revenue Rs. 921.93 Cr, Jammu PLI expansion, novel antibiotic pipeline, and 2026-27 growth outlook.
Stablepharma company profile: Business model, pipeline, and growth outlook (2026 edition)
Stablepharma is a UK biotech developing fridge-free vaccines and injectables via its StablevaX platform. Explore its Phase 1 pipeline, AFT Pharmaceuticals partnership, and 2026-2027 growth outlook.
ServiceNow company profile: Business model, financials, and growth outlook (2025 edition)
Discover how ServiceNow’s AI-native platform, Q1 FY25 performance, and global expansion strategy are redefining enterprise automation—read the full profile.